These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17490936)

  • 1. The stumble-from pipe cleaner to bone builder.
    Swislocki AL; Wexler JA
    Endocr Pract; 2007; 13(2):194-7. PubMed ID: 17490936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of bisphosphonates.
    Breuil V
    Rev Rhum Engl Ed; 1999 Jun; 66(6):339-43. PubMed ID: 10418063
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).
    Timchenko TP
    Sovrem Tekhnologii Med; 2022; 14(2):68-78. PubMed ID: 37065429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V; De Broe M; Ketteler M
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: pharmacology, mechanisms of action and clinical uses.
    Russell RG; Croucher PI; Rogers MJ
    Osteoporos Int; 1999; 9 Suppl 2():S66-80. PubMed ID: 10525729
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.
    Green JR; Müller K; Jaeggi KA
    J Bone Miner Res; 1994 May; 9(5):745-51. PubMed ID: 8053405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two novel bisphosphonates on bone cells in vitro.
    Evans CE; Braidman IP
    Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical bisphosphonate augments fixation of bone-grafted hydroxyapatite coated implants, BMP-2 causes resorption-based decrease in bone.
    Baas J; Vestermark M; Jensen T; Bechtold J; Soballe K; Jakobsen T
    Bone; 2017 Apr; 97():76-82. PubMed ID: 28082076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate treatment of bone disease.
    Shaw NJ; Bishop NJ
    Arch Dis Child; 2005 May; 90(5):494-9. PubMed ID: 15851432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: pharmacology and effects on the growing skeleton.
    Papapoulos SE
    Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates in oncology.
    Coleman RE; McCloskey EV
    Bone; 2011 Jul; 49(1):71-6. PubMed ID: 21320652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates in orthopaedic surgery.
    Morris CD; Einhorn TA
    J Bone Joint Surg Am; 2005 Jul; 87(7):1609-18. PubMed ID: 15995133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):817-24. PubMed ID: 11348880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of chitosan microspheres containing bisphosphonates.
    Patashnik S; Rabinovich L; Golomb G
    J Drug Target; 1997; 4(6):371-80. PubMed ID: 9239577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticalcification and antiresorption effects of bisacylphosphonates.
    Van Gelder JM; Breuer E; Ornoy A; Schlossman A; Patlas N; Golomb G
    Bone; 1995 May; 16(5):511-20. PubMed ID: 7654466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
    Azuma Y; Sato H; Oue Y; Okabe K; Ohta T; Tsuchimoto M; Kiyoki M
    Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current controversies in bisphosphonate therapy.
    Paul GR
    Orthopedics; 2010 Jul; 33(7):468. PubMed ID: 20608598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.